Blogroll
How sewer science could ease testing pressure and track COVID-19
    The science of sewage surveillance could be deployed in countries across the world to help monitor the spread of national epidemics of COVID-19 while reducing the need for mass testing, scientists say.
  
  
  
    Categories: Health  
France says equal access to any Sanofi virus vaccine is non-negotiable
    France on Thursday said equal access to any coronavirus vaccine  developed by Sanofi was non-negotiable and that no country such as the United States should have priority because of financial motivations.
  
  
  
    Categories: Health  
Coronavirus vaccine possible in about a year, says EU agency
    A vaccine to counter the new coronavirus could be approved in about a year in an "optimistic" scenario, a agency which approves medicines for the European Union said on Thursday.
  
  
  
    Categories: Health  
Yemen reports first coronavirus cases in Al Dhalea province
    Yemen's Saudi-backed government on Thursday reported the first cases of the novel coronavirus in the southern province of Al Dhalea, among 15 new infections that took the total in areas under its control to 85 with 12 deaths.
  
  
  
    Categories: Health  
Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir
    Two health advocacy groups have written to the Indian government asking it to rescind patents given to Gilead Sciences  for the drug remdesivir so it can be distributed more fairly to coronavirus patients around the world, particularly in poorer nations.
  
  
  
    Categories: Health  
France to go ahead with digital tax this year regardless of possible international deal
    France will go ahead with its tax on big digital businesses this year whether there is progress or not towards an international deal on the issue, its finance minister said on Thursday.
  
  
  
    Categories: Technology  
CureVac's coronavirus vaccine candidate triggered immune response in animal tests
    Germany's unlisted CureVac said its experimental coronavirus vaccine was shown to trigger an immune response in animals when given a low dose and the biotech firm was looking at carrying out its first human trials in June.
  
  
  
    Categories: Health  
Moscow to launch free mass coronavirus tests from May 15: mayor
    Moscow will begin free mass testing of citizens for the coronavirus from May 15, Moscow Mayor Sergei Sobyanin said on his website on Thursday, with a target of 100,000 people a day by the end of the month.
  
  
  
    Categories: Health  
Around 148,000 people in England had coronavirus recently: estimate
    Around 148,000 people in England had COVID-19 in recent weeks, according to results on Thursday from a large-scale study in Britain into the spread of the disease.
  
  
  
    Categories: Health  
Indonesia's chronic testing lag undermines fight against COVID-19
    More than a month after Indonesian President Joko Widodo promised to ramp up coronavirus testing, medical workers are complaining of persistent delays in the process.
  
  
  
    Categories: Health  
Irish reproduction rate 0.4 to 0.6 ahead of lockdown easing
    The number of people in Ireland infected by someone who has tested positive for the new coronavirus stands at 0.4 to 0.6 ahead of the planned gradual reopening of the economy next week, Health Minister Simon Harris said on Thursday.
  
  
  
    Categories: Health  
UK follows EU, U.S. to approve Roche COVID-19 antibody tests
    Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.
  
  
  
    Categories: Health  
Nvidia launches chip aimed at data center economics
    Semiconductor firm Nvidia Corp on Thursday announced a new chip that can be digitally split up to run several different programs on one physical chip, a first for the company that matches a key capability on many of Intel Corp's chips.
  
  
  
    Categories: Technology  
Le Maire: France to go ahead with digital tax this year regardless of international deal
    France will go ahead with plans to apply a tax on digital businesses this year whether or not there is an international deal on the issue, Finance Minister Bruno Le Maire said on Thursday.
  
  
  
    Categories: Technology  
CureVac's coronavirus vaccine candidate triggered immune response in lab tests
    Germany's unlisted Curevac said its experimental coronavirus vaccine was shown to trigger an immune response in lab tests when used at a low dose and that the biotech firm would start first tests on humans in June.
  
  
  
    Categories: Health  
Nvidia turns to driver-assistance market as robo-taxis stall
    Nvidia Corp, whose semiconductors power data centers, autonomous cars and robots, said on Thursday it plans to enter the market for technology that helps cars with automated lane-keeping, cruise control and other driver-assistance features.
  
  
  
    Categories: Technology  
Antibody test approval is an 'important breakthrough': UK PM's spokesman
    Britain's approval of a COVID-19 antibody test is an "important breakthrough" and might lead to Britons being able to use health certificates if antibodies are present, a spokesman for Prime Minister Boris Johnson said on Thursday.
  
  
  
    Categories: Health  
UK COVID-19 death toll rises by 428 to 33,614
    The COVID-19 death toll in the United Kingdom rose by 428 to 33,614, health officials said on Thursday.
  
  
  
    Categories: Health  
LabCorp to make COVID-19 testing services available at workplaces
    Diagnostic services provider LabCorp said on Thursday it would make its COVID-19 tests available at workplaces, as employers across the United States look to bring people back to work safely.
  
  
  
    Categories: Health  
Sanofi to meet French presidential officials next week to clear up vaccine stir: Elysee
    Sanofi officials will attend a high-level meeting at the Elysee palace next week after comments by the French drugmaker that vaccines produced in the United States could go to U.S. patients first upset President Emmanuel Macron, an Elysee official said on Thursday.
  
  
  
    Categories: Health  









